Subscribe To

Price Alert Latest News Economic Calendar News

SPNS / Sapiens International Corporation N.V. (SPNS) CEO Roni Dor on Q1 2022 Results - Earnings Call Transcript

Sapiens International Corporation N.V. (NASDAQ:SPNS ) Q1 2022 Earnings Conference Call May 3, 2022 9:30 AM ET Company Participants Tally Kaplan - Director, Corporate Marketing Roni Dor - President and Chief Executive Officer Roni Giladi - Chief Financial Officer Alex Zukerman - Chief Strategy Officer Conference Call Participants Surinder Thind - Jefferies Mayank Tandon - Needham & Company Chris Reimer - Barclays Dylan Becker - William Blair Omri Lapidot - Leumi Partners Operator Welcome to Sapiens International Corporation's 2022 First Quarter Financial Results Call. Read More

Demo Live Account See Partner Details

Content Topics

Sapiens

International

Corporation

SPNS

Roni

2022

spns

Results

Earnings

Transcript

Stock

Posted: May 8 2022, 10:08

Author Name: Seeking Alpha

SPNS News

By Zacks Investment Research
September 8, 2023

Sapiens (SPNS) Rides on Strong Clientele & Solid Partner Base

Sapiens (SPNS) is benefiting from an expanding clientele, thanks to a robust portfolio and strong partner base.

By Seeking Alpha
August 2, 2023

Sapiens International Corporation N.V. (SPNS) Q2 2023 Earnings Call Transcript

Sapiens International Corporation N.V. (NASDAQ:SPNS ) Q2 2023 Results Conference Call August 2, 2023 9:30 AM ET Company Participants Yaffa Cohen-Ifrah

By Zacks Investment Research
August 2, 2023

Sapiens (SPNS) Q2 Earnings Meet Estimates

Sapiens (SPNS) came out with quarterly earnings of $0.33 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.27 per

By Seeking Alpha
July 7, 2023

Sapiens International Expects Higher Revenue Growth In 2023

Sapiens International Corporation N.V. provides a range of insurance industry software and managed services worldwide. Management has raised its 2023

By Zacks Investment Research
June 26, 2023

Sapiens (SPNS) Rides on Strong DACH Presence & Partner Base

Sapiens (SPNS) is benefiting from a strong presence in DACH countries, a robust portfolio and an expanding clientele.

By Zacks Investment Research
May 3, 2023

Sapiens (SPNS) Lags Q1 Earnings Estimates

Sapiens (SPNS) came out with quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings

By Seeking Alpha
May 3, 2023

Sapiens: High-Quality Vertical Software Company, Trading For Trough 15x P/E, Estimates Rising

Sapiens sells insurance software for policy, billing, and claims, which is sold to P&C, life, reinsurance, and workers comp insurers. The software is

By Zacks Investment Research
March 7, 2023

Sapiens' (SPNS) Expanding Customer Base Aids Growth Prospects

Sapiens' (SPNS) strong product portfolio addresses the digitization needs of the Insurance sector, which attract new customers.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.